HPGDS and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, in meta-analysis was shown that genetic variants in the genes encoding GSTs may not only play a role in the development of CML, but also affect the response of patients to tyrosine kinase inhibitor (TKI) treatment.